Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations (Q38049779)

27 August 2017

title

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations (English)

1 reference

27 August 2017

1 reference

12

1 reference

27 August 2017

13

1 reference

27 August 2017

Fernando Gomollón

8

0 references

Paolo Gionchetti

Paolo Gionchetti

5

0 references

Winfried Häuser

Winfried Häuser

9

0 references

Jürgen Stein

Jürgen Stein

15

0 references

Axel Dignass

2

Axel Dignass

1 reference

27 August 2017

1

Gert Van Assche

1 reference

27 August 2017

14

Gerhard Rogler

1 reference

27 August 2017

7

Laurent Beaugerie

1 reference

27 August 2017

4

Silvio Danese

1 reference

27 August 2017

11

Bas Oldenburg

1 reference

27 August 2017

Bernd Bokemeyer

3

1 reference

27 August 2017

Gabriele Moser

6

1 reference

27 August 2017

Klaus Herrlinger

10

1 reference

27 August 2017

Herbert Tilg

16

1 reference

27 August 2017

Simon Travis

17

1 reference

27 August 2017

James O Lindsay

18

1 reference

27 August 2017

European Crohn's and Colitis Organisation

19

1 reference

27 August 2017

publication date

3 October 2012

1 reference

Journal of Crohn's and Colitis

27 August 2017

published in

1 reference

27 August 2017

volume

7

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

1-33

1 reference

IIeal Pouch-Anal Anastomoses Complications and Function in 1005 Patients

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Clinical approach to diseases of ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Restorative proctocolectomy with ileal reservoir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Long-term results of the ileoanal pouch procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Ileo-anal pouch function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Pouchitis: result of microbial imbalance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Systematic review: the management of pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

21 January 2018

Collagenous pouchitis

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

21 January 2018

Etiology of pouchitis*

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Perioperative factors during ileal pouch-anal anastomosis predict pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Colorectal cancer prevention in ulcerative colitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Dysplasia and cancer complicating strictures in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Judgement of the Quality of Bowel Preparation at Screening Flexible Sigmoidoscopy is Associated with Variability in Adenoma Detection Rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Most dysplasia in ulcerative colitis is visible at colonoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

5-Aminosalicylate Is Not Chemoprophylactic for Colorectal Cancer in IBD: A Population Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Diagnosis and management of dysplasia in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Management of neoplastic polyps in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The role of psychological stress in inflammatory bowel disease: quality assessment of methods of 18 prospective studies and suggestions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Does stress influence inflammatory bowel disease? The clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The need for a new medical model: a challenge for biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Depression and anxiety in people with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A prospective population-based study of triggers of symptomatic flares in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Determinants of life satisfaction in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Inflammatory bowel diseases as multi-focal disorders: results from a multi-regional survey on bodily and psychosocial problems in IBD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Health status and health care use in persons with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Psychosocial correlates of patient-physician discordance in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Internet use by patients in an inflammatory bowel disease specialty clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Internet use among inflammatory bowel disease patients: an Italian multicenter survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Providing disease-related information worsens health-related quality of life in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Assessing the demand for psychological care in chronic diseases: development and validation of a questionnaire based on the example of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Does psychological counseling alter the natural history of inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Evaluation of a psychological treatment for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Relaxation training as a treatment for chronic pain caused by ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Psychological interventions for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Antidepressants and inflammatory bowel disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Extraintestinal manifestations in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Muscoloskeletal manifestations in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

An assessment tool for predicting fracture risk in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Important cutaneous manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Skin ulcers misdiagnosed as pyoderma gangrenosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Diagnosis and treatment of pyoderma gangrenosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Ocular manifestations of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The medical management of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Hospitalization-based major comorbidity of inflammatory bowel disease in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Inflammation and coagulation in inflammatory bowel disease: The clot thickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Anemia in IBD: the overlooked villain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Evolution of adverse changes in stored RBCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohńs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Systematic review: managing anaemia in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Anemia and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Haemoglobin adjustments to define anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

An update on iron physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Intravenous iron: from anathema to standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Update on adverse drug events associated with parenteral iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Prevalence and outcomes of anemia in cancer: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Use of agents stimulating erythropoiesis in digestive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

The hazards of blood transfusion in historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Oral budesonide in the treatment of chronic refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Extraintestinal Manifestations of Crohn’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

Vertebral Fractures and Role of Low Bone Mineral Density in Crohn’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/J.CROHNS.2012.09.005

10.1016/J.CROHNS.2012.09.005

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference